Does the media favor PRCT or LIVN?

In the previous week, PROCEPT BioRobotics had 24 more articles in the media than LivaNova. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 7 mentions for LivaNova. LivaNova's average media sentiment score of 0.53 beat PROCEPT BioRobotics' score of 0.11 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 1 Very Positive mention(s) 1 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ITGR or PRCT?

In the previous week, PROCEPT BioRobotics had 20 more articles in the media than Integer. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 11 mentions for Integer. Integer's average media sentiment score of 0.58 beat PROCEPT BioRobotics' score of 0.11 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 5 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 1 Very Positive mention(s) 1 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PLSE or PRCT?

In the previous week, PROCEPT BioRobotics had 25 more articles in the media than Pulse Biosciences. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 6 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.74 beat PROCEPT BioRobotics' score of 0.11 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PROCEPT BioRobotics 1 Very Positive mention(s) 1 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to PRCT or IRTC?

In the previous week, PROCEPT BioRobotics had 29 more articles in the media than iRhythm Technologies. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 2 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.62 beat PROCEPT BioRobotics' score of 0.11 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 1 Very Positive mention(s) 1 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to PRCT or TMDX?

In the previous week, PROCEPT BioRobotics had 19 more articles in the media than TransMedics Group. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 12 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.68 beat PROCEPT BioRobotics' score of 0.11 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 1 Very Positive mention(s) 1 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TransMedics Group 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

PROCEPT BioRobotics (PRCT) Competitors

$19.30 -0.17 (-0.87%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$19.30 +0.00 (+0.03%)

As of 09/18/2026 07:30 PM Eastern

Compare

PRCT vs. LIVN, ITGR, PLSE, IRTC, and TMDX

Should you buy PROCEPT BioRobotics stock or one of its competitors? PROCEPT BioRobotics's main competitors and comparable companies include LivaNova (LIVN), Integer (ITGR), Pulse Biosciences (PLSE), iRhythm Technologies (IRTC), and TransMedics Group (TMDX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does PROCEPT BioRobotics compare to LivaNova?

PROCEPT BioRobotics (NASDAQ:PRCT) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by insiders. Comparatively, 0.4% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

PROCEPT BioRobotics has higher earnings, but lower revenue than LivaNova. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.59	-$95.57M	-$1.94	N/A
LivaNova	$1.39B	3.10	-$242.47M	$3.38	23.08

PROCEPT BioRobotics has a beta of 0.91, suggesting that its share price is 9% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market.

LivaNova has a net margin of 12.82% compared to PROCEPT BioRobotics' net margin of -32.53%. LivaNova's return on equity of 16.35% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
LivaNova	12.82%	16.35%	7.76%

In the previous week, PROCEPT BioRobotics had 24 more articles in the media than LivaNova. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 7 mentions for LivaNova. LivaNova's average media sentiment score of 0.53 beat PROCEPT BioRobotics' score of 0.11 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	1 Very Positive mention(s)	1 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PROCEPT BioRobotics currently has a consensus target price of $25.09, indicating a potential upside of 30.00%. LivaNova has a consensus target price of $84.13, indicating a potential upside of 7.84%. Given PROCEPT BioRobotics' higher possible upside, analysts plainly believe PROCEPT BioRobotics is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.20
LivaNova	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.55

Summary

LivaNova beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Integer?

Integer (NYSE:ITGR) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, media sentiment, analyst recommendations, institutional ownership and profitability.

Integer currently has a consensus price target of $109.86, indicating a potential downside of 13.05%. PROCEPT BioRobotics has a consensus price target of $25.09, indicating a potential upside of 30.00%. Given PROCEPT BioRobotics' stronger consensus rating and higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
PROCEPT BioRobotics	2 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.20

In the previous week, PROCEPT BioRobotics had 20 more articles in the media than Integer. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 11 mentions for Integer. Integer's average media sentiment score of 0.58 beat PROCEPT BioRobotics' score of 0.11 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	5 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	1 Very Positive mention(s)	1 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Integer has a net margin of 6.97% compared to PROCEPT BioRobotics' net margin of -32.53%. Integer's return on equity of 12.79% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

99.3% of Integer shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Integer has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market.

Integer has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$3.66	34.52
PROCEPT BioRobotics	$308.05M	3.59	-$95.57M	-$1.94	N/A

Summary

Integer beats PROCEPT BioRobotics on 9 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and PROCEPT BioRobotics (NASDAQ:PRCT) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, analyst recommendations, profitability, dividends and valuation.

Pulse Biosciences has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Comparatively, PROCEPT BioRobotics has a beta of 0.91, suggesting that its stock price is 9% less volatile than the broader market.

Pulse Biosciences currently has a consensus price target of $45.25, suggesting a potential downside of 16.00%. PROCEPT BioRobotics has a consensus price target of $25.09, suggesting a potential upside of 30.00%. Given PROCEPT BioRobotics' higher probable upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
PROCEPT BioRobotics	2 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.20

77.0% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are owned by institutional investors. 74.0% of Pulse Biosciences shares are owned by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Pulse Biosciences has higher earnings, but lower revenue than PROCEPT BioRobotics. Pulse Biosciences is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$350K	10,897.13	-$72.78M	-$1.18	N/A
PROCEPT BioRobotics	$308.05M	3.59	-$95.57M	-$1.94	N/A

In the previous week, PROCEPT BioRobotics had 25 more articles in the media than Pulse Biosciences. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 6 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.74 beat PROCEPT BioRobotics' score of 0.11 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PROCEPT BioRobotics	1 Very Positive mention(s)	1 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PROCEPT BioRobotics has a net margin of -32.53% compared to Pulse Biosciences' net margin of -6,755.78%. PROCEPT BioRobotics' return on equity of -30.62% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%

Summary

Pulse Biosciences and PROCEPT BioRobotics tied by winning 8 of the 16 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to iRhythm Technologies?

PROCEPT BioRobotics (NASDAQ:PRCT) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, dividends, valuation and profitability.

In the previous week, PROCEPT BioRobotics had 29 more articles in the media than iRhythm Technologies. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 2 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.62 beat PROCEPT BioRobotics' score of 0.11 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	1 Very Positive mention(s)	1 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

iRhythm Technologies has higher revenue and earnings than PROCEPT BioRobotics. iRhythm Technologies is trading at a lower price-to-earnings ratio than PROCEPT BioRobotics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.59	-$95.57M	-$1.94	N/A
iRhythm Technologies	$747.14M	4.82	-$44.55M	-$0.43	N/A

iRhythm Technologies has a net margin of -1.69% compared to PROCEPT BioRobotics' net margin of -32.53%. iRhythm Technologies' return on equity of 10.11% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
iRhythm Technologies	-1.69%	10.11%	1.53%

PROCEPT BioRobotics currently has a consensus target price of $25.09, suggesting a potential upside of 30.00%. iRhythm Technologies has a consensus target price of $179.93, suggesting a potential upside of 64.57%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.20
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

PROCEPT BioRobotics has a beta of 0.91, meaning that its share price is 9% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 4.0% of PROCEPT BioRobotics shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

iRhythm Technologies beats PROCEPT BioRobotics on 13 of the 17 factors compared between the two stocks.

How does PROCEPT BioRobotics compare to TransMedics Group?

PROCEPT BioRobotics (NASDAQ:PRCT) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, PROCEPT BioRobotics had 19 more articles in the media than TransMedics Group. MarketBeat recorded 31 mentions for PROCEPT BioRobotics and 12 mentions for TransMedics Group. TransMedics Group's average media sentiment score of 0.68 beat PROCEPT BioRobotics' score of 0.11 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PROCEPT BioRobotics	1 Very Positive mention(s)	1 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TransMedics Group	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

PROCEPT BioRobotics has a beta of 0.91, indicating that its share price is 9% less volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.9, indicating that its share price is 90% more volatile than the broader market.

TransMedics Group has a net margin of 22.69% compared to PROCEPT BioRobotics' net margin of -32.53%. TransMedics Group's return on equity of 15.88% beat PROCEPT BioRobotics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PROCEPT BioRobotics	-32.53%	-30.62%	-22.10%
TransMedics Group	22.69%	15.88%	5.95%

PROCEPT BioRobotics currently has a consensus price target of $25.09, indicating a potential upside of 30.00%. TransMedics Group has a consensus price target of $121.10, indicating a potential upside of 40.13%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts plainly believe TransMedics Group is more favorable than PROCEPT BioRobotics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PROCEPT BioRobotics	2 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.20
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.33

89.5% of PROCEPT BioRobotics shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 4.0% of PROCEPT BioRobotics shares are owned by company insiders. Comparatively, 6.9% of TransMedics Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

TransMedics Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PROCEPT BioRobotics	$308.05M	3.59	-$95.57M	-$1.94	N/A
TransMedics Group	$605.49M	4.93	$190.29M	$3.89	22.22

Summary

TransMedics Group beats PROCEPT BioRobotics on 15 of the 17 factors compared between the two stocks.

Get PROCEPT BioRobotics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PRCT vs. The Competition

Export

Metric	PROCEPT BioRobotics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.12B	$5.53B	$7.25B	$13.13B
Dividend Yield	N/A	1.79%	2.57%	12.94%
P/E Ratio	-9.95	25.11	273.81	25.39
Price / Sales	3.59	72.24	692.78	109.00
Price / Cash	N/A	32.72	77.42	51.66
Price / Book	2.95	5.74	10.45	6.33
Net Income	-$95.57M	$151.55M	$3.48B	$358.24M
7 Day Performance	-5.30%	0.66%	0.88%	1.17%
1 Month Performance	-11.91%	-3.84%	-1.59%	-2.59%
1 Year Performance	-48.38%	6.85%	18.08%	5.97%

PROCEPT BioRobotics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PRCT PROCEPT BioRobotics	4.0981 of 5 stars	$19.30 -0.9%	$25.09 +30.0%	-49.3%	$1.12B	$308.05M	N/A	888	Trending News
LIVN LivaNova	2.6816 of 5 stars	$80.63 +3.1%	$84.13 +4.3%	+39.5%	$4.31B	$1.39B	23.86	3,300
ITGR Integer	2.8154 of 5 stars	$126.16 +0.1%	$109.86 -12.9%	+21.3%	$4.28B	$1.85B	34.47	11,000	Insider Trade
PLSE Pulse Biosciences	1.8753 of 5 stars	$54.21 +2.1%	$45.25 -16.5%	+190.9%	$3.68B	$350K	N/A	116	Positive News
IRTC iRhythm Technologies	3.9038 of 5 stars	$114.72 +3.0%	$179.93 +56.8%	-38.0%	$3.67B	$747.14M	N/A	2,400	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PRCT) was last updated on 9/19/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. LIVN, ITGR, PLSE, IRTC, and TMDX

How does PROCEPT BioRobotics compare to LivaNova?

Summary

How does PROCEPT BioRobotics compare to Integer?

Summary

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Summary

How does PROCEPT BioRobotics compare to TransMedics Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

PROCEPT BioRobotics (PRCT) Competitors

PRCT vs. LIVN, ITGR, PLSE, IRTC, and TMDX

How does PROCEPT BioRobotics compare to LivaNova?

Do insiders & institutionals believe in PRCT or LIVN?

Which has better valuation & earnings, PRCT or LIVN?

Which has more risk & volatility, PRCT or LIVN?

Is PRCT or LIVN more profitable?

Does the media favor PRCT or LIVN?

Do analysts recommend PRCT or LIVN?

Summary

How does PROCEPT BioRobotics compare to Integer?

Do analysts prefer ITGR or PRCT?

Does the media favor ITGR or PRCT?

Is ITGR or PRCT more profitable?

Do institutionals and insiders hold more shares of ITGR or PRCT?

Which has more volatility and risk, ITGR or PRCT?

Which has better earnings & valuation, ITGR or PRCT?

Summary

How does PROCEPT BioRobotics compare to Pulse Biosciences?

Which has more volatility & risk, PLSE or PRCT?

Do analysts rate PLSE or PRCT?

Do institutionals & insiders hold more shares of PLSE or PRCT?

Which has better earnings & valuation, PLSE or PRCT?

Does the media prefer PLSE or PRCT?

Is PLSE or PRCT more profitable?

Summary

How does PROCEPT BioRobotics compare to iRhythm Technologies?

Does the media refer more to PRCT or IRTC?

Which has better valuation and earnings, PRCT or IRTC?

Is PRCT or IRTC more profitable?

Do analysts recommend PRCT or IRTC?

Which has more volatility & risk, PRCT or IRTC?

Do institutionals and insiders have more ownership in PRCT or IRTC?

Summary

How does PROCEPT BioRobotics compare to TransMedics Group?

Does the media refer more to PRCT or TMDX?

Which has more risk and volatility, PRCT or TMDX?

Is PRCT or TMDX more profitable?

Do analysts rate PRCT or TMDX?

Do institutionals and insiders believe in PRCT or TMDX?

Which has preferable earnings and valuation, PRCT or TMDX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PRCT vs. The Competition

PROCEPT BioRobotics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools